← USPTO Patent Applications

REDUCED DOSING REGIMENS FOR GLAUCOMA TREATMENT

Application US20260083746A1 Kind: A1 Mar 26, 2026

Inventors

Dennis Elias Saadeh

Abstract

Methods for treating open-angle glaucoma include transitioning a patient from a twice-per-day or more treatment regimen to a once-per-day treatment regimen. The once-per-day treatment include administering a single dose of a pharmaceutical composition including timolol or a pharmaceutically acceptable salt thereof, brimonidine or a pharmaceutically acceptable salt thereof, dorzolamide or a pharmaceutically acceptable salt thereof, and bimatoprost or a pharmaceutically acceptable salt thereof, once per day.

CPC Classifications

A61K 31/5377 A61K 9/0048 A61K 31/382 A61K 31/498 A61K 31/5575 A61K 47/02 A61K 47/10 A61K 47/12 A61K 47/26 A61P 27/06

Filing Date

2025-09-25

Application No.

19339566